MiMedx Group Announces Changes to Board of Directors

Human amniotic membrane-derived device company MiMedx Group, Inc., has announced that its Board of Directors has appointed two new members, effective September 5, 2012. The new directors are healthcare executive Charles R. Evans and Neil S. Yeston, M.D., F.A.C.S., a healthcare practitioner, innovator and leader.



MiMedx Group Announces Changes to Board of Directors (via PR Newswire)

KENNESAW, Ga., Sept. 10, 2012 /PRNewswire/ — MiMedx Group, Inc.  (OTCBB: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its Board of Directors has appointed two new members…


published: September 11, 2012 in: People, Plastic/Reconstructive

Most read

Latest

^